JP2024525797A5 - - Google Patents
Info
- Publication number
- JP2024525797A5 JP2024525797A5 JP2024502035A JP2024502035A JP2024525797A5 JP 2024525797 A5 JP2024525797 A5 JP 2024525797A5 JP 2024502035 A JP2024502035 A JP 2024502035A JP 2024502035 A JP2024502035 A JP 2024502035A JP 2024525797 A5 JP2024525797 A5 JP 2024525797A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocycloalkyl
- independently selected
- heteroatoms independently
- bond
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221905P | 2021-07-14 | 2021-07-14 | |
| US63/221,905 | 2021-07-14 | ||
| PCT/US2022/037029 WO2023287928A1 (en) | 2021-07-14 | 2022-07-13 | Bifunctional compounds for degrading btk with diminished imid activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525797A JP2024525797A (ja) | 2024-07-12 |
| JP2024525797A5 true JP2024525797A5 (cg-RX-API-DMAC7.html) | 2025-07-22 |
Family
ID=82799901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502035A Pending JP2024525797A (ja) | 2021-07-14 | 2022-07-13 | 減少したIMiD活性を伴ってBTKを分解するための二官能性化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240336595A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370123A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024525797A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240035837A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118019538A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022310182A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3225367A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309796A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023287928A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3867242A1 (en) | 2018-10-15 | 2021-08-25 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| EP3924350A1 (en) | 2019-02-13 | 2021-12-22 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| CA3160713A1 (en) | 2019-12-04 | 2021-06-10 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| KR20240029070A (ko) * | 2021-07-01 | 2024-03-05 | 항저우 힐젠 테라퓨틱스 컴퍼니 리미티드 | 브루톤 티로신 키나아제, 이의 돌연변이체 분해제, 조성물 및 응용 |
| MX2024004899A (es) | 2021-10-26 | 2024-05-24 | Nurix Therapeutics Inc | Compuestos de piperidinilpirazina-carboxamida para tratar y prevenir el cancer y para degradar btk. |
| WO2025162210A1 (zh) * | 2024-02-04 | 2025-08-07 | 上海超阳药业有限公司 | 一种具备降解酪氨酸蛋白激酶btk活性的化合物及其制备方法和用途 |
| TW202606657A (zh) * | 2024-06-27 | 2026-02-16 | 南韓商韓美藥品股份有限公司 | 新型異雙功能蛋白質降解劑以及包含其的藥物組成物 |
| CN120590386A (zh) * | 2025-05-30 | 2025-09-05 | 北京科莱博医药开发有限责任公司 | 一种喹喔啉类蛋白降解剂及其制备方法和应用 |
| CN120617259B (zh) * | 2025-06-05 | 2026-04-10 | 南昌大学第一附属医院 | Btk protac化合物nx-5948的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3867242A1 (en) | 2018-10-15 | 2021-08-25 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| CA3160713A1 (en) | 2019-12-04 | 2021-06-10 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
-
2022
- 2022-07-13 IL IL309796A patent/IL309796A/en unknown
- 2022-07-13 CN CN202280061966.9A patent/CN118019538A/zh active Pending
- 2022-07-13 EP EP22751224.1A patent/EP4370123A1/en active Pending
- 2022-07-13 WO PCT/US2022/037029 patent/WO2023287928A1/en not_active Ceased
- 2022-07-13 AU AU2022310182A patent/AU2022310182A1/en active Pending
- 2022-07-13 KR KR1020247004956A patent/KR20240035837A/ko active Pending
- 2022-07-13 JP JP2024502035A patent/JP2024525797A/ja active Pending
- 2022-07-13 US US18/579,114 patent/US20240336595A1/en active Pending
- 2022-07-13 CA CA3225367A patent/CA3225367A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023504147A5 (cg-RX-API-DMAC7.html) | ||
| JP2024526984A5 (cg-RX-API-DMAC7.html) | ||
| USRE49556E1 (en) | Compounds and compositions as protein kinase inhibitors | |
| JP7158383B2 (ja) | C-kit阻害剤としてのベンズイミダゾール化合物 | |
| AU2017376624B2 (en) | Aminothiazole compounds as c-Kit inhibitors | |
| AU2015331166B2 (en) | Compounds and compositions for modulating EGFR mutant kinase activities | |
| JP2018532737A5 (cg-RX-API-DMAC7.html) | ||
| JP2023507669A (ja) | ピリド[3,4-d]ピリミジン誘導体およびこれを含む治療用薬学組成物 | |
| JP2021525781A (ja) | 核輸送モジュレーターとしての化合物およびその使用 | |
| JP2021535207A5 (cg-RX-API-DMAC7.html) | ||
| AU2019381808A1 (en) | ERK inhibitors and uses thereof | |
| JP2019530745A5 (cg-RX-API-DMAC7.html) | ||
| CA2568608A1 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| RU2018134981A (ru) | Конъюгаты, содержащие ингибиторы RIPK2 | |
| JP2016514718A5 (cg-RX-API-DMAC7.html) | ||
| JP2019521109A5 (cg-RX-API-DMAC7.html) | ||
| JP2016520131A5 (cg-RX-API-DMAC7.html) | ||
| RU2012124811A (ru) | СПОСОБ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И ДРУГИХ ПАТОЛОГИЧЕСКИХ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ АКТИВНОСТЬЮ КИНАЗ Bcr-Abl, c-Kit, DDR1, DDR2, ИЛИ PDGF-R | |
| RU2014118677A (ru) | Ингибиторы киназ типа polo | |
| RU2016101548A (ru) | Соединения амидов гетероарилпиридона и азапиридона | |
| EP4237418B1 (en) | Pyrimidine compounds, compositions, and medicinal applications thereof | |
| IL257392A (en) | The troarils are converted to pyrazolil and their use as drugs | |
| EP4136073A1 (en) | Substituted pyridines for the treatment of inflammatory diseases | |
| RU2018102087A (ru) | Производное 1,4-дизамещенного имидазола | |
| JP2023531495A5 (cg-RX-API-DMAC7.html) |